Agarwal Shefali

CIK 00017468303 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001746830

Recent Transactions

50 trades

Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2025-05-29+55,000→ 55,000 total
Other
Gritstone bio, Inc.
Stock Option (Right to Buy)
2025-04-04−19,000→ 0 total
Other
Gritstone bio, Inc.
Stock Option (Right to Buy)
2025-04-04−51,800→ 0 total
Other
Gritstone bio, Inc.
Stock Option (Right to Buy)
2025-04-04−51,800→ 0 total
Other
Gritstone bio, Inc.
Stock Option (Right to Buy)
2025-04-04−937→ 0 total
Other
Gritstone bio, Inc.
Stock Option (Right to Buy)
2025-04-04−38,000→ 0 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2024-06-17+51,800→ 51,800 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2024-06-07+40,000→ 40,000 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2023-06-16+51,800→ 51,800 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2023-06-06+40,000→ 40,000 total
Disposition to Issuer
Epizyme, Inc.
Common Stock, par value $0.0001
2022-08-12−179,247→ 107,292 total
Disposition to Issuer
Epizyme, Inc.
Common Stock, par value $0.0001
2022-08-12−107,292→ 0 total
Tax Payment
Epizyme, Inc.
Common Stock, par value $0.0001
2022-08-09$1.39/sh−373,154→ 285,562 total
Exercise/Conversion
Epizyme, Inc.
Common Stock, par value $0.0001
2022-08-09$1.39/sh+56,527→ 215,243 total
Exercise/Conversion
Epizyme, Inc.
Common Stock, par value $0.0001
2022-08-09$1.39/sh+43,473→ 258,716 total
Exercise/Conversion
Epizyme, Inc.
Common Stock, par value $0.0001
2022-08-09$1.39/sh+400,000→ 658,716 total
Exercise/Conversion
Epizyme, Inc.
Stock Option (Right to Buy)
2022-08-09−43,473→ 400,000 total
Exercise/Conversion
Epizyme, Inc.
Stock Option (Right to Buy)
2022-08-09−56,527→ 443,473 total
Exercise/Conversion
Epizyme, Inc.
Stock Option (Right to Buy)
2022-08-09−400,000→ 0 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2022-06-17+19,000→ 19,000 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2022-06-09+8,650→ 10,490 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2022-06-09+11,893→ 11,893 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-06-07$21.89/sh−841→ 1,840 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-06-03$22.80/sh−807→ 1,874 total
Sale
FATE THERAPEUTICS INC$FATE
Common Stock
2022-06-03−0→ 2,681 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2022-03-17+500,000→ 500,000 total
Award
Epizyme, Inc.
Common Stock
2022-02-28$1.27/sh+2,331→ 158,716 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2022-02-07$1.50/sh−1,058→ 156,385 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2022-02-02$1.37/sh−2,639→ 157,443 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2022-01-26$2.02/sh−2,922→ 160,082 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2021-12-06$2.93/sh−1,780→ 163,004 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2021-08-16+59,166→ 163,507 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2021-08-16+282,270→ 282,270 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2021-06-18+937→ 937 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (Right to Buy)
2021-06-02+4,334→ 4,334 total
Award
FATE THERAPEUTICS INC$FATE
Common Stock
2021-06-02+2,681→ 2,681 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2021-06-01+38,000→ 38,000 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2021-02-04$11.21/sh−969→ 104,341 total
Award
Epizyme, Inc.
Common Stock
2021-02-01+29,583→ 105,310 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2021-02-01+141,135→ 141,135 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2021-01-25$11.41/sh−2,872→ 75,727 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2020-12-03$13.54/sh−2,522→ 76,089 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2020-06-26$16.15/sh−1,805→ 78,611 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2020-06-25+6,000→ 80,416 total
Award
FATE THERAPEUTICS INC$FATE
Stock Option (right to buy)
2020-05-01+16,000→ 16,000 total
Sale
Epizyme, Inc.
Common Stock, par value $0.0001
2020-03-25$15.28/sh−1,243→ 71,991 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2020-03-24+1,575→ 73,234 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2020-03-24+4,000→ 74,416 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2020-02-03+61,834→ 61,834 total
Award
Epizyme, Inc.
Common Stock
2020-02-03+12,856→ 71,659 total

Companies

Recent Filings

Address

C/O FATE THERAPEUTICS, INC. 12278 SCRIPPS SUMMIT DRIVE

SAN DIEGO, CA, 92131

View on SEC.gov